Related Experiment Video
Updated: Mar 23, 2026
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Use of Biomarkers
1Prof. Leocadio Rodríguez Mañas, Jefe de Servicio de Geriatría, Hospital Universitario de Getafe, Ctra. de Toledo, Km. 12,5, 28905-Getafe, Spain, Phone: 00 34 916839360 (ext. 6412), Fax: 00 34 916839210,
Current frailty assessments lack accuracy in clinical settings. The FRAILOMIC project investigates combining biological biomarkers to improve frailty diagnosis, risk, and prognosis assessment.
Area of Science:
- Gerontology
- Biomarkers
- Clinical Medicine
Background:
- Current clinical frailty assessment tools exhibit low sensitivity and low positive predictive value.
- Frailty is a complex condition resulting from multi-systemic failures.
- There is a need for more accurate methods to identify frail individuals in clinical practice.
Purpose of the Study:
- To evaluate the effectiveness of biological biomarkers in improving frailty assessment.
- To determine if combining multiple biomarkers enhances accuracy for frailty diagnosis, risk, and prognosis.
- To validate biomarkers as reliable clinical markers for frailty.
Main Methods:
- Review of identified frailty biomarkers.
- Assessment of combined biomarker sets.
- Evaluation of biomarker performance against classical frailty definitions.
- Utilizing data from the EU-funded FRAILOMIC project.
Main Results:
- Identified numerous potential frailty biomarkers.
- Observed controversial results regarding the clinical utility of individual biomarkers.
- Investigating the synergistic effect of combined biomarkers.
Conclusions:
- Combining multiple biological biomarkers shows promise for improving the accuracy of frailty assessment.
- Biomarker panels may offer a more feasible and accurate approach to frailty diagnosis, risk stratification, and prognosis in clinical settings.
- Further research is warranted to validate combined biomarker panels for clinical application.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:17Microbial Biosensors